Exhibit 99.1 CLEARMIND MEDICINE INC. Condensed Interim Consolidated Financial Statements For The Three Months Ended January 31, 2024 (Expressed in United States Dollars) (Unaudited) CLEARMIND MEDICINE INC. Condensed Interim Consolidated Statements of Financial Position (Expressed in United States Dollars) (Unaudited) January 31, October 31, 2024 2023 Assets Current assets Cash and cash equivalents $9,285,973$ 5,427,739 Other receivables 68,491 104,320 Short-term investment (Note 3) 86,668 86,112 Prepaid e ...